<unk> (oral) is an acetylcholinesterase inhibitor that is FDA approved for the treatment of mild to moderate dementia of the alzheimer’s type and mild to moderate dementia associated with parkinson’s disease.   Common adverse reactions include nausea, vomiting, anorexia, dyspepsia, and asthenia.
Rivastigmine 
Trifluperidol
Melevodopa
Diphenidol
Perhexiline
Memantine
Bunaftine
Meptazinol